S. Serra et al. / Tetrahedron: Asymmetry 14 (2003) 3313–3319
3319
{[h]2D0=−11 (c 3.5, CHCl3), lit.29 [h]2D0=+18.6 (c 3.45,
References
CHCl3), was reduced as described above to give (−)-cis-
piperitol 11 {[h]2D0=−107.5 (c 2, EtOH)} and (+)-trans-
piperitol 10 {[h]2D0=+19.1 (c 2, EtOH)}. The two alcohols
were submitted to the general procedure of acetylation
using lipase PS as catalyst and the reaction was stopped
at about 70 and 30% of conversion, respectively. The two
mixtures were purified by chromatography to give enan-
tiopure (+)-trans piperitol {[h]2D0=+30.5 (c 2, EtOH) 98%
e.e.} and (−)-cis-piperitol acetate {[h]2D0=−378.2 (c 2,
CHCl3) 99% e.e.}. The latter acetate give after saponifi-
cation (−)-cis-piperitol {[h]2D0=−206 (c 2, EtOH)}.
1. Pybus, D. H.; Sell, C. S. The Chemistry of Fragrances; The
Royal Society of Chemistry: Cambridge, 1999; pp. 67–76.
2. Noboru, S.; Takaji, M. European Patent EP 1153908A2,
14/11/2001.
3. Bain, J. P.; Hunt, H. G.; Klein, E. A.; Booth, A. B. United
States Patent US 2972632, 21/02/1961.
4. Brenna, E.; Fuganti, C.; Serra, S. Tetrahedron: Asymmetry
2003, 14, 1–42.
5. Yamamoto, T. European Patent EP 0694514A2, 31/01/
1996.
6. Akutagawa, S. In Chirality in Industry; Collins, A. N.;
Sheldracke, G. N.; Crosby, J., Eds.; John Wiley, 1992; pp.
313–323.
7. Vorlova, S.; Bornscheuer, U. T.; Gatfield, I.; Hilmer, J.-M.;
Bertram, H.-J.; Schmid, R. D. Adv. Synth. Catal. 2002, 344,
1152–1155.
8. Gatfield, I.; Hilmer, J.-M.; Bornscheuer, U. T.; Schmid, R.
D.; Vorlova, S. European Patent EP1223223A1, 17/07/
2002.
9. Chaplin, J. A.; Gardiner, N. S.; Mitra, R. K.; Parkinson,
C. J.; Portwig, M.; Mboniswa, B. A.; Dickson, M. D. E.;
Brady, D.; Marais, S. F.; Reddy, S. International Patent
WO02/36795A2, 10/05/2002.
10. Lin, G.; Lin, W.-Y. Tetrahedron Lett. 1998, 39, 4333–4336.
11. Wu, W.-H.; Akoh, C. C.; Phillips, R. S. Enzyme Microb.
Technol. 1996, 18, 536–539.
12. Persichetti, R. A.; Lalonde, J. J.; Govardhan, C. P.;
Khalaf, N. K.; Margolin, A. L. Tetrahedron Lett. 1996, 37,
6507–6510.
13. Langrand, G.; Baratti, J.; Buono, G.; Triantaphylides, C.
Tetrahedron Lett. 1986, 27, 29–32.
14. Langrand, G.; Secchi, M.; Buono, G.; Baratti, J.; Trianta-
phylides, C. Tetrahedron Lett. 1985, 26, 1857–1860.
15. Serra, S.; Fuganti, C. Helv. Chim. Acta 2002, 85, 2489–
2502.
4.3.8. Resolution of racemic cis-isopiperitenol. A mixture
of racemic 12 and 13 (cis/trans 9:1) was used as substrate
in the general procedure of resolution. The use of lipase
PS as catalyst gave (−)-cis-isopiperitenol acetate 26 (98%
GC), [h]2D0=−378 (c 2, CHCl3), chiral GC (tR 45.22)
e.e.=99%, d.e. 80%, 1H NMR (cis-isomer), l, ppm: 5.60
(1H, m, H-C(2)), 5.37 (1H, m, H-C(3)), 4.85 (1H, s,
H-C(9)), 4.73 (1H, s, H-C(9)), 2.22–2.00 (3H, m), 1.97
(3H, s, OAc), 1.97–1.60 (2H, m), 1.77 and 1.73 (6H, s+s,
Me(7) and Me(10)); m/z (EI): 194 (M+, 1), 179 (1), 152
(27), 134 (84), 126 (13), 119 (45), 105 (18), 91 (35), 84
(100), 77 (16), 43 (26); FT-IR (film) 2935, 1732, 1674,
1648, 1441, 1371, 1239, 1021, 957, 910, 890 cm−1; and
(+)-cis-isopiperitenol 12 (98% GC), [h]2D0=+213 (c 2,
CHCl3), chiral GC (tR 45.79) e.e.=92%, d.e. 80%. The
use of CRL as catalyst gave (−)-cis-isopiperitenol acetate
(98% GC), [h]2D0=−297 (c 2, CHCl3), chiral GC e.e.=
89%, d.e. 86% and (+)-isopiperitenol (98% GC), [h]2D0=
+79 (c 2, CHCl3); chiral GC e.e.=55%, d.e. 76%.
Saponification of the acetate samples gave pure (−)-cis-
isopiperitenol [h]D20=−228 (c 2, EtOH) and [h]2D0=−210
(c 2, EtOH), respectively.
4.4. Determination of the absolute configuration of cis-
piperitenol
16. Friedrich, D.; Bohlmann, F. Tetrahedron 1988, 44, 1369–
1392.
4.4.1. Preparation of isopiperitenone. A solution of (+)-
cis-isopiperitenol 12 (1.5 g, 9.9 mmol, {[h]2D0=+213 (c 2,
CHCl3), e.e.=92%, d.e. 80%} in CH2Cl2 (30 mL) was
treated with MnO2 (4 g, 46 mmol) stirring at rt for 2 h.
The reaction was filtered and the solution was concen-
trated under reduced pressure. The residue was purified
by chromatography (hexane–ether, 95:5) and bulb-to-
bulb distillation (oven temp. 80–85°/0.6 mmHg) to afford
pure (98% GC) (S)-(+)-isopiperitenone 27 (1.3 g, 8.7
mmol, 87%, [h]D20=+30.1 (c 2, CHCl3)), lit.24 [h]D20=+49
(c 0.96, CHCl3); 1H NMR, l, ppm: 5.90 (1H, bq, J=1.5
Hz, H-C(2)), 4.95 (1H, m, H-C(9)), 4.76 (1H, m, H-C(9)),
2.95 (1H, dd, J=5.3, 10.3 Hz, H-C(4)), 2.40–2.30 (2H,
m), 2.20–1.99 (2H, m), 1.96 (3H, s, Me(7)), 1.75 (3H, bq,
J=0.7 Hz, Me(10)); m/z (EI): 150 (M+, 19), 135 (28), 122
(6), 117 (1), 107 (7), 91 (4), 82 (100), 67 (4), 54 (13); FT-IR
(film) 3075, 2936, 1671, 1648, 1438, 1380, 1319, 1201,
1025, 891 cm−1.
17. Corey, E. J.; Ensley, H. E.; Suggs, J. W. J. Org. Chem.
1976, 41, 380–381.
18. Eschinasi, E. H. J. Org. Chem. 1970, 35, 2010–2012.
19. Schenck, G. O.; Gollnick, K.; Buchwald, G.; Schroeter, S.;
Ohloff, G. Liebigs Ann. Chem. 1964, 674, 93–117.
20. Macbeth, A. K.; Shannon, J. S. J. Chem. Soc. 1952,
2852–2856.
21. Guillon, J.; Rioult, J.-P.; Robba, M. Flavour Fragr. J. 2000,
15, 223–224 and references cited therein.
22. Marshall, J. A.; Lebreton, J. J. Org. Chem. 1988, 53,
4108–4112.
23. Fisher, R. Deutsches Patent 2305629, 14/08/1974.
24. Anglea, T. A.; Pinder, A. R. Tetrahedron 1987, 43, 5537–
5543.
25. Banks, R. E.; Miller, J. A.; Nunn, M. J.; Stanley, P.;
Weakley, T. J. R.; Ullah, Z. J. Chem. Soc., Perkin Trans.
1 1981, 1096–1102.
26. Kocienski, P. J.; Pontiroli, A.; Qun, L. J. Chem. Soc.,
Perkin Trans. 1 2001, 2356–2366.
27. Juo, R.-R.; Herz, W. J. Org. Chem. 1985, 50, 700–703.
28. Catin, A.; Lull, C.; Primo, J.; Miranda, M. A.; Primo-
Yufera, E. Tetrahedron: Asymmetry 2001, 12, 677–683.
29. Hiroi, K.; Umemura, M. Tetrahedron 1993, 49, 1831–1840.
Acknowledgements
The financial support of COFIN-MURST is
acknowledged.